Friday, April 27, 2018
Check-in & Lunch: 12:00 pm
Program: 12:15 pm-1:15 pm

Manchester Grand Hyatt
1 Market Place
San Diego, CA 92101
Room: Harbor H, Second Level

Sponsored by the Cardiovascular Research Foundation
Supported through an educational grant from Medtronic

This program is accredited for Continuing Medical Education (CME).

This event is not part of the official Annual SCAI Scientific Sessions as planned by the SCAI Program Committee.


The next decade in the field of interventional cardiology and vascular medicine is poised to be filled with innovation. The landscape promises tremendous advancements in treatment, including the introduction of new techniques and novel concepts for existing products.

Patients with aortic stenosis, traditionally treated surgically, can now be treated with less-invasive, catheter-based procedures. With widening indications for use in patients ranging from low- to extremely high-risk, transcatheter aortic valve replacement (TAVR) has continued to show promise as an intervention that ultimately improves patient comfort and safety. Likewise, as evidence for the use of transradial PCI continues to grow, this increasingly utilized approach has shown promise for improving upon patient outcomes seen in femoral access PCI. As these interventional innovations continue to advance from theory to concept, practitioners must critically evaluate the prospect of integration into everyday practice.

This program shares insights on the future of endograft repair of aortic aneurysm, as well as on stroke reduction in TAVR. It also explores how advanced imaging affects how patients are selected for PCI and how the procedure is performed, with particular emphasis on the growing use of radial access, or transradial PCI. During this educational forum, practitioners gain critical knowledge on the future of the interventional pipeline and how it can positively impact their practice.

Learning Objectives

By the end of this program, the attendees will be able to:

  • Assess the treatment pipeline for the next decade in the field of cardiovascular medicine
  • Compare current treatment strategies to future innovations
  • Evaluate the impact that new practice strategies will have on patient outcomes

The Cardiovascular Research Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Cardiovascular Research Foundation designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This educational activity is designed for interventional cardiologists, clinical cardiologists, and other healthcare professionals involved in the management of PCI patients.

Evaluation by questionnaire will address content, presentation effectiveness, possible bias, and future educational needs.

This program is sponsored by the Cardiovascular Research Foundation and supported through an educational grant from Medtronic. The Cardiovascular Research Foundation ensures that its programs are educational and meet the needs of the target audience. This program was developed without influence from commercial supporters.

It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and therefore, does not compromise the scientific integrity of the educational activity.

Discussion of off-label product usage is made at the sole discretion of the faculty. Off-label product discussion and usage is not endorsed by the Cardiovascular Research Foundation, nor the course directors of this activity.

Faculty participating in medical education activities sponsored by the Cardiovascular Research Foundation are required to disclose to the activity audience any real or apparent conflicts of interest related to the content of their presentations. Faculty in noncompliance with this policy are not permitted to participate in this activity.



Roxana Mehran, MD, FACC The Mount Sinai Hospital
New York, NY


Sahil A. Parikh, MD NewYork-Presbyterian/
Columbia University Medical Center
New York, NY

Sunil V. Rao, MD Duke University Medical Center
Durham, NC



{{}} and {{lecturer}},



{{}} and {{lecturer}},



{{}} and {{lecturer}},


There is no cost to register. You must be a SCAI 2018 registrant to attend this satellite program.

Should you have any questions, please contact
Catherine Brosnan at

Register Now